Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $10,539 - $12,473
1,099 Added 3.38%
33,638 $331,000
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $4,038 - $5,382
439 Added 1.37%
32,539 $313,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $17,832 - $23,640
-2,045 Reduced 5.99%
32,100 $357,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $59,478 - $78,065
7,014 Added 25.85%
34,145 $291,000
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $30,626 - $37,767
3,078 Added 12.8%
27,131 $284,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $89,565 - $140,602
9,130 Added 61.18%
24,053 $262,000
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $180,419 - $219,069
14,923 New
14,923 $202,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.